- Filed
- May 12, 2026 12:00 AM ET
- Period of report
- —
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2026 · May 8, 2026 | 23.46M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2026 | 22.64M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2025 | 16.72M sh |
| Operating Cash Flow | Q1 2026 · Mar 31, 2026 | −$6.21M |
| Operating Cash Flow | Q1 2026 · Mar 31, 2025 | −$2.83M |
| Cash And Equivalents | Q1 2026 · Mar 31, 2026 | $50.72M |
| Cash And Equivalents | Q1 2026 · Dec 31, 2025 | $46.82M |
| Stockholders Equity | Q1 2026 · Mar 31, 2026 | $48.97M |
| Stockholders Equity | Q1 2026 · Dec 31, 2025 | $43.03M |
| Stockholders Equity | Q1 2026 · Mar 31, 2025 | $33.37M |
| Stockholders Equity | Q1 2026 · Dec 31, 2024 | $39.58M |
| Current Liabilities | Q1 2026 · Mar 31, 2026 | $3.55M |
| Current Liabilities | Q1 2026 · Dec 31, 2025 | $5.87M |
| Total Liabilities | Q1 2026 · Mar 31, 2026 | $4.3M |
| Total Liabilities | Q1 2026 · Dec 31, 2025 | $6.92M |
| Current Assets | Q1 2026 · Mar 31, 2026 | $53.26M |
| Current Assets | Q1 2026 · Dec 31, 2025 | $49.94M |
| Total Assets | Q1 2026 · Mar 31, 2026 | $53.27M |
| Total Assets | Q1 2026 · Dec 31, 2025 | $49.95M |
| Eps Diluted | Q1 2026 · Mar 31, 2026 | −$0.32 |
| Eps Diluted | Q1 2026 · Mar 31, 2025 | −$0.44 |
| Eps Basic | Q1 2026 · Mar 31, 2026 | −$0.32 |
| Eps Basic | Q1 2026 · Mar 31, 2025 | −$0.44 |
| Sga Expense | Q1 2026 · Mar 31, 2026 | $3.78M |
| Sga Expense | Q1 2026 · Mar 31, 2025 | $2.71M |
| Net Income | Q1 2026 · Mar 31, 2026 | −$7.21M |
| Net Income | Q1 2026 · Mar 31, 2025 | −$7.31M |
| Operating Income | Q1 2026 · Mar 31, 2026 | −$7.64M |
| Operating Income | Q1 2026 · Mar 31, 2025 | −$7.68M |
| Revenue | Q1 2026 · Mar 31, 2026 | $251.15K |
| Revenue | Q1 2026 · Mar 31, 2025 | $257.88K |